Initiation of the ATM-Chk2 DNA damage response through the base excision repair pathway

Carcinogenesis

Volumn 36, Issue 8, 2015, Pages 832-840

  Chou, Wen Cheng ^a   Hu, Ling Yueh ^a   Hsiung, Chia Ni ^a   Shen, Chen Yang ^a,b,c  

^a INSTITUTE OF BIOMEDICAL SCIENCES   (Taiwan)

^b ACADEMIA SINICA   (Taiwan)

^c CHINA MEDICAL UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

8 HYDROXYGUANINE; ATM PROTEIN; CHECKPOINT KINASE 2; DEOXYRIBONUCLEASE I; DNA GLYCOSYLTRANSFERASE; URACIL DNA GLYCOSIDASE; AFIMOXIFENE; APEX1 PROTEIN, HUMAN; ATM PROTEIN, HUMAN; CCNO PROTEIN, HUMAN; CHEK2 PROTEIN, HUMAN; DNA (APURINIC OR APYRIMIDINIC SITE) LYASE; MESYLIC ACID METHYL ESTER; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; OXOGUANINE GLYCOSYLASE 1, HUMAN; PARP1 PROTEIN, HUMAN; TAMOXIFEN;

ARTICLE; CELL DEATH; CONTROLLED STUDY; DEAMINATION; DNA ALKYLATION; DOWNSTREAM PROCESSING; EXCISION REPAIR; FEMALE; GENE OVEREXPRESSION; GENE SILENCING; HELA CELL LINE; HUMAN; HUMAN CELL; LETHALITY; MCF 7 CELL LINE; OXIDATIVE STRESS; PRIORITY JOURNAL; SINGLE STRANDED DNA BREAK; ANALOGS AND DERIVATIVES; BREAST NEOPLASMS; CELL LINE; DNA DAMAGE; DNA REPAIR; DRUG EFFECTS; GENE EXPRESSION REGULATION; GENETICS; IONIZING RADIATION; METABOLISM; MORTALITY; PATHOLOGY; PHYSIOLOGY; RADIATION RESPONSE; REFERENCE VALUE;

ATAXIA TELANGIECTASIA MUTATED PROTEINS; BREAST NEOPLASMS; CELL LINE; CHECKPOINT KINASE 2; DNA DAMAGE; DNA GLYCOSYLASES; DNA REPAIR; DNA-(APURINIC OR APYRIMIDINIC SITE) LYASE; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE KNOCKDOWN TECHNIQUES; HUMANS; METHYL METHANESULFONATE; POLY(ADP-RIBOSE) POLYMERASES; RADIATION, IONIZING; REFERENCE VALUES; TAMOXIFEN;

EID: 84938686739     PISSN: 01433334     EISSN: 14602180     Source Type: Journal    
DOI: 10.1093/carcin/bgv079     Document Type: Article

References (50)

1. Negrini, S. et al. (2010) Genomic instability-an evolving hallmark of cancer. Nat. Rev. Mol. Cell Biol., 11, 220-228.
2. Branzei, D. et al. (2008) Regulation of DNA repair throughout the cell cycle. Nat. Rev. Mol. Cell Biol., 9, 297-308.
3. Shiloh, Y. et al. (2013) The ATM protein kinase: regulating the cellular response to genotoxic stress, and more. Nat. Rev. Mol. Cell Biol., 14, 197-210.
4. Nam, E.A. et al. (2011) ATR signalling: more than meeting at the fork. Biochem. J., 436, 527-536.
5. De Bont, R. et al. (2004) Endogenous DNA damage in humans: a review of quantitative data. Mutagenesis, 19, 169-185.
6. Fu, D. et al. (2012) Balancing repair and tolerance of DNA damage caused by alkylating agents. Nat. Rev. Cancer, 12, 104-120.
7. Monti, P. et al. (2010) Mutagenicity of N3-methyladenine: a multi-translesion polymerase affair. Mutat. Res., 683, 50-56.
8. Wallace, S.S. (2002) Biological consequences of free radical-damaged DNA bases. Free Radic. Biol. Med., 33, 1-14.
9. Brem, R. et al. (2008) The methyl methanesulfonate induced S-phase delay in XRCC1-deficient cells requires ATM and ATR. DNA Repair (Amst)., 7, 849-857.
10. Wallace, S.S. et al. (2012) Base excision repair and cancer. Cancer Lett., 327, 73-89.
11. Robertson, A.B. et al. (2009) DNA repair in mammalian cells: Base excision repair: the long and short of it. Cell. Mol. Life Sci., 66, 981-993.
12. Luke, A.M. et al. (2010) Accumulation of true single strand breaks and AP sites in base excision repair deficient cells. Mutat. Res., 694, 65-71.
13. Pachkowski, B.F. et al. (2009) Cells deficient in PARP-1 show an accelerated accumulation of DNA single strand breaks, but not AP sites, over the PARP-1-proficient cells exposed to MMS. Mutat. Res., 671, 93-99.
14. Shrivastav, N. et al. (2010) Chemical biology of mutagenesis and DNA repair: cellular responses to DNA alkylation. Carcinogenesis, 31, 59-70.
15. Khoronenkova, S.V. et al. (2015) ATM prevents DSB formation by coordinating SSB repair and cell cycle progression. Proc. Natl. Acad. Sci. U. S. A., 112, 3997-4002.
16. Chou, W.C. et al. (2008) Chk2-dependent phosphorylation of XRCC1 in the DNA damage response promotes base excision repair. EMBO J., 27, 3140-3150.
17. Kim, Y.C. et al. (2009) Activation of ATM depends on chromatin interactions occurring before induction of DNA damage. Nat. Cell Biol., 11, 92-96.
18. Gyorffy, B. et al. (2012) Implementing an online tool for genome-wide validation of survival-associated biomarkers in ovarian-cancer using microarray data from 1287 patients. Endocr. Relat. Cancer, 19, 197-208.
19. Watanabe, S. et al. (2003) Methylated DNA-binding domain 1 and methylpurine-DNA glycosylase link transcriptional repression and DNA repair in chromatin. Proc. Natl. Acad. Sci. U. S. A., 100, 12859-12864.
20. Zhang, T. et al. (2012) Competition between NBS1 and ATMIN controls ATM signaling pathway choice. Cell Rep., 2, 1498-1504.
21. Connor, E.E. et al. (2002) Active-site clashes prevent the human 3-methyladenine DNA glycosylase from improperly removing bases. Chem. Biol., 9, 1033-1041.
22. Lau, A.Y. et al. (1998) Crystal structure of a human alkylbase-DNA repair enzyme complexed to DNA: mechanisms for nucleotide flipping and base excision. Cell, 95, 249-258.
23. Roy, R. et al. (2000) Mutation of a unique aspartate residue abolishes the catalytic activity but not substrate binding of the mouse N-methylpurine-DNA glycosylase (MPG). J. Biol. Chem., 275, 4278-4282.
24. Likhite, V.S. et al. (2004) Interaction of estrogen receptor alpha with 3-methyladenine DNA glycosylase modulates transcription and DNA repair. J. Biol. Chem., 279, 16875-16882.
25. Ensminger, M. et al. (2014) DNA breaks and chromosomal aberrations arise when replication meets base excision repair. J. Cell Biol., 206, 29-43.
26. Lee, J.H. et al. (2005) ATM activation by DNA double-strand breaks through the Mre11-Rad50-Nbs1 complex. Science, 308, 551-554.
27. Landry, S. et al. (2011) APOBEC3A can activate the DNA damage response and cause cell-cycle arrest. EMBO Rep., 12, 444-450.
28. Doi, T. et al. (2009) The C-terminal region of activation-induced cytidine deaminase is responsible for a recombination function other than DNA cleavage in class switch recombination. Proc. Natl. Acad. Sci. U. S. A., 106, 2758-2763.
29. Feil, R. et al. (1997) Regulation of Cre recombinase activity by mutated estrogen receptor ligand-binding domains. Biochem. Biophys. Res. Commun., 237, 752-757.
30. Visnes, T. et al. (2008) The rate of base excision repair of uracil is controlled by the initiating glycosylase. DNA Repair (Amst)., 7, 1869-1881.
31. Mol, C.D. et al. (1995) Crystal structure and mutational analysis of human uracil-DNA glycosylase: structural basis for specificity and catalysis. Cell, 80, 869-878.
32. Kavli, B. et al. (2007) Uracil in DNA-general mutagen, but normal intermediate in acquired immunity. DNA Repair (Amst)., 6, 505-516.
33. Guo, Z. et al. (2010) ATM activation by oxidative stress. Science, 330, 517-521.
34. Lazzaro, F. et al. (2009) Checkpoint mechanisms at the intersection between DNA damage and repair. DNA Repair (Amst)., 8, 1055-1067.
35. Warmerdam, D.O. et al. (2010) Dealing with DNA damage: relationships between checkpoint and repair pathways. Mutat. Res., 704, 2-11.
36. Ray, A. et al. (2013) NER initiation factors, DDB2 and XPC, regulate UV radiation response by recruiting ATR and ATM kinases to DNA damage sites. DNA Repair (Amst)., 12, 273-283.
37. Yoshioka, K. et al. (2006) ATR kinase activation mediated by MutSalpha and MutLalpha in response to cytotoxic O6-methylguanine adducts. Mol. Cell, 22, 501-510.
38. Meira, L.B. et al. (2014) Repair of endogenous DNA base lesions modulate lifespan in mice. DNA Repair (Amst)., 21, 78-86.
39. Agnihotri, S. et al. (2014) ATM regulates 3-methylpurine-DNA glycosylase and promotes therapeutic resistance to alkylating agents. Cancer Discov., 4, 1198-1213.
40. Adamson, A.W. et al. (2002) ATM is activated in response to N-methyl-N'-nitro-N-nitrosoguanidine-induced DNA alkylation. J. Biol. Chem., 277, 38222-38229.
41. Sartori, A.A. et al. (2007) Human CtIP promotes DNA end resection. Nature, 450, 509-514.
42. White, D. et al. (2012) The ATM substrate KAP1 controls DNA repair in heterochromatin: regulation by HP1 proteins and serine 473/824 phosphorylation. Mol. Cancer Res., 10, 401-414.
43. Elder, R.H. et al. (1998) Alkylpurine-DNA-N-glycosylase knockout mice show increased susceptibility to induction of mutations by methyl methanesulfonate. Mol. Cell. Biol., 18, 5828-5837.
44. Trivedi, R.N. et al. (2008) Human methyl purine DNA glycosylase and DNA polymerase beta expression collectively predict sensitivity to temozolomide. Mol. Pharmacol., 74, 505-516.
45. Tang, J.B. et al. (2011) N-methylpurine DNA glycosylase and DNA polymerase beta modulate BER inhibitor potentiation of glioma cells to temozolomide. Neuro. Oncol., 13, 471-486.
46. Rinne, M.L. et al. (2005) N-methylpurine DNA glycosylase overexpression increases alkylation sensitivity by rapidly removing nontoxic 7-methylguanine adducts. Nucleic Acids Res., 33, 2859-2867.
47. Albarakati, N. et al. (2015) Targeting BRCA1-BER deficient breast cancer by ATM or DNA-PKcs blockade either alone or in combination with cisplatin for personalized therapy. Mol. Oncol., 9, 204-217.
48. Sultana, R. et al. (2013) Targeting XRCC1 deficiency in breast cancer for personalized therapy. Cancer Res., 73, 1621-1634.
49. Curtin, N.J. (2012) DNA repair dysregulation from cancer driver to therapeutic target. Nat. Rev. Cancer, 12, 801-817.
50. Horton, J.K. et al. (2013) Predicting enhanced cell killing through PARP inhibition. Mol. Cancer Res., 11, 13-18.